Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

JACC: Cardiovascular Interventions

Volumn 9, Issue 16, 2016, Pages 1706-1717

  Abdul Jawad Altisent, Omar ^a   Durand, Eric ^b   Muñoz García, Antonio J ^c   Nombela Franco, Luis ^d   Cheema, Asim ^e   Kefer, Joelle ^f   Gutierrez, Enrique ^g   Benítez, Luis M ^h   Amat Santos, Ignacio J ⁱ   Serra, Vicenç ^j   Eltchaninoff, Helene ^b   Alnasser, Sami M ^e   Elízaga, Jaime ^g   Dager, Antonio ^h   García del Blanco, Bruno ^j   Ortas Nadal, Maria del Rosario ^a   Marsal, Josep Ramon ^j,k   Campelo Parada, Francisco ^a   Regueiro, Ander ^a   del Trigo, Maria ^a   Dumont, Eric ^a   Puri, Rishi ^a   Rodés Cabau, Josep ^a   more..

^a LAVAL UNIVERSITY   (Canada)

^b HÔPITAL CHARLES NICOLLE   (France)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^g HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^h Clinica de Occidente   (Colombia)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^j HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^k CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

more..

Author keywords

bleeding; stroke; transcatheter aortic valve replacement; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT; VITAMIN K GROUP;

ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; EPISTAXIS; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART DEATH; HEART INFARCTION; HEMOPERICARDIUM; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PERCUTANEOUS AORTIC VALVE; PRIORITY JOURNAL; RESPIRATORY TRACT HEMORRHAGE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT DURATION; UROGENITAL TRACT DISEASE; ADVERSE EFFECTS; AGED; ANTAGONISTS AND INHIBITORS; AORTIC VALVE; BLOOD; BRAIN ISCHEMIA; CANADA; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; EUROPE; HEART VALVE DISEASES; KAPLAN MEIER METHOD; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STROKE; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; AORTIC VALVE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CANADA; CHI-SQUARE DISTRIBUTION; EUROPE; FEMALE; HEART VALVE DISEASES; HEMORRHAGE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME; VITAMIN K; WARFARIN;

EID: 84990975989     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.06.025     Document Type: Article

References (22)

1. 1 Iung, B., Rodés-Cabau, J., The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties. Eur Heart J 35 (2014), 2942–2949.
2. 2 Holmes, D.R. Jr., Mack, M.J., Kaul, S., et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 59 (2012), 1200–1254.
3. 3 Mok, M., Urena, M., Nombela-Franco, L., et al. Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation. J Thromb Thrombolysis 35 (2013), 450–455.
4. 4 Hansen, M.L., Sorensen, R., Clausen, M.T., et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 170 (2010), 1433–1441.
5. 5 Genereux, P., Cohen, D.J., Mack, M., et al. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. J Am Coll Cardiol 64 (2014), 2605–2615.
6. 6 Puri, R., Altisent, O.A., Campelo-Parada, F., Del Trigo, M., Regueiro, A., Rodés-Cabau, J., Balancing the risks of thrombosis and bleeding following transcatheter aortic valve implantation: current state-of-evidence. Curr Pharm Des 22 (2015), 1904–1910.
7. 7 Rodés-Cabau, J., Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 9 (2012), 15–29.
8. 8 Kappetein, A.P., Head, S.J., Genereux, P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 33 (2012), 2403–2418.
9. 9 Mehran, R., Rao, S.V., Bhatt, D.L., et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123 (2011), 2736–2747.
10. 10 Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129 (2014), e521–e643.
11. 11 Vahanian, A., Alfieri, O., Andreotti, F., et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33 (2012), 2451–2496.
12. 12 Webb, J., Rodés-Cabau, J., Fremes, S., et al. Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement. Can J Cardiol 28 (2012), 520–528.
13. 13 Dewilde, W.J.M., Oirbans, T., Verheugt, F.W.A., et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381 (2013), 1107–1115.
14. 14 Nombela-Franco, L., Webb, J.G., de Jaegere, P.P., et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 126 (2012), 3041–3053.
15. 15 Rodés-Cabau, J., Dauerman, H.L., Cohen, M.G., et al. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. J Am Coll Cardiol 62 (2013), 2349–2359.
16. 16 Fanning, J.P., Walters, D.L., Platts, D.G., Eeles, E., Bellapart, J., Fraser, J.F., Characterization of neurological injury in transcatheter aortic valve implantation: how clear is the picture?. Circulation 129 (2014), 504–515.
17. 17 Heras, M., Chesebro, J.H., Fuster, V., et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 25 (1995), 1111–1119.
18. 18 Turpie, A.G., Gent, M., Laupacis, A., et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 329 (1993), 524–529.
19. 19 Brennan, J.M., Edwards, F.H., Zhao, Y., et al. Early anticoagulation of bioprosthetic aortic valves in older patients. Results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. J Am Coll Cardiol 60 (2012), 971–977.
20. 20 Dentali, F., Douketis, J.D., Lim, W., Crowther, M., Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. Arch Intern Med 167 (2007), 117–124.
21. 21 Lamberts, M., Gislason, G.H., Lip, G.Y., et al. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Circulation 129 (2014), 1577–1585.
22. 22 Amsterdam, E.A., Wenger, N.K., Brindis, R.G., et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64 (2014), e139–e228.